|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 239.28 USD | -1.01% |
|
+4.38% | +12.21% |
| Capitalization | 12.59B 14.78B 11.65B 10.97B 20.44B 1,375B 20.86B 137B 53.5B 660B 55.48B 54.3B 2,352B | P/E ratio 2026 * |
49.2x | P/E ratio 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise value | 11.98B 14.07B 11.09B 10.44B 19.45B 1,308B 19.85B 130B 50.91B 628B 52.79B 51.67B 2,239B | EV / Sales 2026 * |
8.71x | EV / Sales 2027 * | 5.81x |
| Free-Float |
97.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ascendis Pharma A/S
| 1 day | -1.01% | ||
| 1 week | +4.38% | ||
| Current month | +4.61% | ||
| 1 month | +4.48% | ||
| 3 months | +14.62% | ||
| 6 months | +14.19% | ||
| Current year | +12.21% |
| 1 week | 216.53 |  | 246.76 |
| 1 month | 212.6 | | 246.76 |
| Current year | 188.08 | | 248.6 |
| 1 year | 150.89 | | 248.6 |
| 3 years | 66.03 | | 248.6 |
| 5 years | 61.58 | | 248.6 |
| 10 years | 11.92 | | 248.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jan Mikkelsen
CEO | Chief Executive Officer | 67 | 01/12/2007 |
Scott Smith
DFI | Director of Finance/CFO | 53 | 08/08/2016 |
Aimee Shu
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/07/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Mikkelsen
BRD | Director/Board Member | 67 | 01/12/2007 |
Albert Cha
CHM | Chairman | 54 | 28/05/2021 |
Lisa Bright
BRD | Director/Board Member | 59 | 01/04/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +4.38% | +58.47% | +191.93% | 14.78B | |
| -1.30% | +1.39% | -4.10% | -12.28% | 45.62B | |
| -1.20% | -0.36% | +34.42% | +21.49% | 34.34B | |
| -0.89% | +2.25% | +28.92% | +21.96% | 29.46B | |
| -0.97% | -3.42% | +14.97% | -15.48% | 28.09B | |
| +0.22% | -2.71% | +169.96% | +369.02% | 19.11B | |
| +2.31% | -6.43% | +2,918.75% | +3,811.51% | 14.25B | |
| -1.59% | -0.97% | +65.77% | +160.33% | 14.09B | |
| -1.40% | -2.74% | +27.18% | +1.28% | 13.25B | |
| -1.65% | +0.51% | +169.43% | +105.44% | 12.42B | |
| Average | -0.75% | -1.06% | +348.38% | +465.52% | 22.54B | |
| Weighted average by Cap. | -0.85% | -0.73% | +227.87% | +302.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.38B 1.61B 1.27B 1.2B 2.23B 150B 2.28B 14.93B 5.84B 72.1B 6.06B 5.93B 257B | 1.95B 2.29B 1.8B 1.7B 3.16B 213B 3.23B 21.17B 8.28B 102B 8.59B 8.41B 364B |
| Net income | 265M 311M 245M 231M 429M 28.88B 438M 2.87B 1.12B 13.87B 1.17B 1.14B 49.41B | 622M 730M 575M 542M 1.01B 67.86B 1.03B 6.75B 2.64B 32.59B 2.74B 2.68B 116B |
| Net Debt | -609M -715M -564M -531M -989M -66.52B -1.01B -6.62B -2.59B -31.94B -2.68B -2.63B -114B | -1.26B -1.48B -1.17B -1.1B -2.04B -138B -2.09B -13.68B -5.35B -66.04B -5.55B -5.43B -235B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 239.28 $ | -1.01% | 687,205 |
| 09/04/26 | 241.71 $ | +3.65% | 882,435 |
| 08/04/26 | 233.20 $ | +5.77% | 754,916 |
| 07/04/26 | 220.48 $ | -2.74% | 487,196 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ASND Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition